Clinical Trial Update: Efficacy of Naltrexone in Women's Smoking Cessation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the efficacy of naltrexone for smoking cessation in women; completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoking
• Smoking Cessation

Drugs mentioned

• Naltrexone (Naltrexone)

Snippet

Sponsor: University of Chicago | Conditions: Smoking, Smoking Cessation | Phase 2 | Status: COMPLETED | Results posted: 2013-04-26